GT Biopharma, Inc. Debenture Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
GT Biopharma, Inc. 10% Senior Convertible Debenture Due September 24, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due August 2, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
OXIS International, Inc. 10% Senior Convertible Debenture Due June 30, 2017
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
10% Senior Convertible Debenture Agreement between OXIS International, Inc. and Holder
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
OXIS International, Inc. 10% Senior Convertible Debenture Due July 24, 2016
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2014
Oxis International, Inc. 8% Two-Year Convertible Debenture Agreement
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
First Amendment to 0% Convertible Debenture between Oxis International, Inc. and Debenture Holders
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
2011
OXIS International, Inc. 0% Convertible Debenture Due October 1, 2011
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
Secured Convertible Debenture Agreement between Oxis International, Inc. and Holder (Due October 25, 2008)
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
2006